update on share purchase agreement dated July 29, 2026 with Actis Generics Private Limited

September 24, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Corporate Relationship Department Plot No. C-1, G- Block, 25, P.J. Towers, Bandra - Kurla Complex, Bandra (East) Dalal Street, Mumbai – 400 051. Mumbai 400 001. Symbol: RPGLIFE Scrip Code: 532983 Dear Sir/Madam, Subject: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’). Further to our letter dated July 29, 2026, informing you about the execution of Share Purchase Agreement (‘SPA’) by RPG Active Pharma Limited (RPGAP) for acquisition of entire stake of Actis Generics Private Limited (‘Actis’). We wish to inform you that in terms of the SPA, the said transaction has been completed, today i.e. September 24, 2026. Effective from September 24, 2026, Actis has became subsidiary of the Company and the wholly owned subsidiary of RPGAP. Kindly take the same on records. Yours sincerely, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary